A detailed history of California Public Employees Retirement System transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 93,097 shares of CRL stock, worth $17.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,097
Previous 96,653 3.68%
Holding current value
$17.3 Million
Previous $20 Million 8.15%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $668,385 - $872,251
-3,556 Reduced 3.68%
93,097 $18.3 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $314,744 - $409,813
1,525 Added 1.6%
96,653 $20 Million
Q1 2024

Apr 30, 2024

SELL
$203.52 - $273.43 $179,708 - $241,438
-883 Reduced 0.92%
95,128 $25.8 Million
Q4 2023

Feb 01, 2024

SELL
$164.52 - $238.84 $487,308 - $707,444
-2,962 Reduced 2.99%
96,011 $22.7 Million
Q3 2023

Nov 02, 2023

BUY
$194.44 - $217.61 $552,404 - $618,230
2,841 Added 2.96%
98,973 $19.4 Million
Q2 2023

Aug 09, 2023

SELL
$183.71 - $210.25 $482,238 - $551,906
-2,625 Reduced 2.66%
96,132 $20.2 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $2.54 Million - $3.44 Million
-13,218 Reduced 11.8%
98,757 $19.9 Million
Q4 2022

Feb 08, 2023

SELL
$197.11 - $250.07 $311,039 - $394,610
-1,578 Reduced 1.39%
111,975 $24.4 Million
Q3 2022

Nov 09, 2022

BUY
$182.44 - $250.54 $3.01 Million - $4.13 Million
16,486 Added 16.98%
113,553 $22.3 Million
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $784,471 - $1.16 Million
-3,843 Reduced 3.81%
97,067 $20.8 Million
Q1 2022

May 04, 2022

SELL
$255.51 - $362.11 $1.94 Million - $2.75 Million
-7,595 Reduced 7.0%
100,910 $28.7 Million
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $1.52 Million - $1.94 Million
-4,313 Reduced 3.82%
108,505 $40.9 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $204,579 - $251,606
-549 Reduced 0.48%
112,818 $46.6 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $1.02 Million - $1.28 Million
-3,457 Reduced 2.96%
113,367 $41.9 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $550,272 - $660,053
-2,204 Reduced 1.85%
116,824 $33.9 Million
Q4 2020

Feb 02, 2021

BUY
$222.0 - $252.62 $1.26 Million - $1.43 Million
5,659 Added 4.99%
119,028 $29.7 Million
Q3 2020

Nov 05, 2020

BUY
$175.56 - $226.45 $372,713 - $480,753
2,123 Added 1.91%
113,369 $25.7 Million
Q2 2020

Aug 12, 2020

BUY
$118.84 - $189.72 $272,856 - $435,597
2,296 Added 2.11%
111,246 $19.4 Million
Q1 2020

May 12, 2020

SELL
$98.9 - $178.34 $4.56 Million - $8.22 Million
-46,069 Reduced 29.72%
108,950 $13.8 Million
Q4 2019

Jan 27, 2020

BUY
$126.05 - $152.76 $5.5 Million - $6.66 Million
43,603 Added 39.14%
155,019 $23.7 Million
Q3 2019

Oct 31, 2019

BUY
$125.07 - $143.67 $4.38 Million - $5.03 Million
35,030 Added 45.86%
111,416 $14.7 Million
Q2 2019

Aug 15, 2019

SELL
$123.4 - $148.55 $445,844 - $536,711
-3,613 Reduced 4.52%
76,386 $10.8 Million
Q1 2019

May 03, 2019

SELL
$104.82 - $146.73 $575,881 - $806,134
-5,494 Reduced 6.43%
79,999 $11.6 Million
Q4 2018

Feb 08, 2019

SELL
$105.09 - $137.23 $965,882 - $1.26 Million
-9,191 Reduced 9.71%
85,493 $9.68 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $693,624 - $832,398
-6,187 Reduced 6.13%
94,684 $12.7 Million
Q2 2018

Aug 15, 2018

BUY
$102.37 - $117.25 $311,204 - $356,440
3,040 Added 3.11%
100,871 $11.3 Million
Q1 2018

May 11, 2018

BUY
$98.19 - $115.2 $731,711 - $858,470
7,452 Added 8.25%
97,831 $10.4 Million
Q4 2017

Feb 06, 2018

BUY
$100.43 - $118.09 $1.23 Million - $1.44 Million
12,224 Added 15.64%
90,379 $9.89 Million
Q3 2017

Nov 15, 2017

BUY
$96.72 - $109.26 $7.56 Million - $8.54 Million
78,155
78,155 $8.44 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.